My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Pacira BioSciences, Inc. - Common Stock (NQ:PCRX)

21.73 UNCHANGED

Streaming Delayed Price Updated: 4:15 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Pacira BioSciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts ↗

April 09, 2024

Via Benzinga

Despite its impressive fundamentals, NASDAQ:PCRX remains undervalued. ↗

March 28, 2024

PACIRA BIOSCIENCES INC (NASDAQ:PCRX) appears to be flying under the radar despite its strong fundamentals.

Via Chartmill

Navigating 4 Analyst Ratings For Pacira BioSciences ↗

March 01, 2024

Via Benzinga

When you look at NASDAQ:PCRX, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation. ↗

March 01, 2024

Don't overlook PACIRA BIOSCIENCES INC (NASDAQ:PCRX)—it's a hidden gem with strong fundamentals and an attractive price tag.

Via Chartmill

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Preview: Pacira BioSciences's Earnings ↗

February 28, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

February 12, 2024

Via Benzinga

NASDAQ:PCRX is an undervalued gem with solid fundamentals. ↗

January 19, 2024

PACIRA BIOSCIENCES INC (NASDAQ:PCRX), an undervalued stock with good fundamentals.

Via Chartmill

A Glimpse Into The Expert Outlook On Pacira BioSciences Through 7 Analysts ↗

December 20, 2023

Via Benzinga

Earnings Preview: Pacira BioSciences ↗

November 01, 2023

Via Benzinga

NASDAQ:PCRX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

February 09, 2024

PACIRA BIOSCIENCES INC (NASDAQ:PCRX) appears to be flying under the radar despite its strong fundamentals.

Via Chartmill

NASDAQ:PCRX is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. ↗

December 20, 2023

PACIRA BIOSCIENCES INC (NASDAQ:PCRX) is an undervalued gem with solid fundamentals.

Via Chartmill

Investors should take notice of NASDAQ:PCRX—it offers a great deal for the fundamentals it presents. ↗

November 29, 2023

Despite its impressive fundamentals, PACIRA BIOSCIENCES INC (NASDAQ:PCRX) remains undervalued.

Via Chartmill

For those who appreciate value investing, NASDAQ:PCRX is a compelling option with its solid fundamentals. ↗

November 08, 2023

Investors should take notice ofPACIRA BIOSCIENCES INC (NASDAQ:PCRX)—it offers a great deal for the fundamentals it presents.

Via Chartmill

Analyst Expectations for Pacira BioSciences's Future ↗

October 23, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 ↗

August 03, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

September 26, 2023

On Tuesday, 386 stocks made new 52-week lows.

Via Benzinga

4 Analysts Have This to Say About Pacira BioSciences ↗

August 03, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

September 11, 2023

Monday's session saw 175 companies set new 52-week lows.

Via Benzinga

Analyst Ratings for Pacira BioSciences ↗

July 13, 2023

Via Benzinga

Looking Into Pacira BioSciences's Return On Capital Employed ↗

May 09, 2023

Via Benzinga

Recap: Pacira BioSciences Q1 Earnings ↗

May 03, 2023

Via Benzinga

What 6 Analyst Ratings Have To Say About Pacira BioSciences ↗

April 20, 2023

Via Benzinga

Analyst Expectations for Pacira BioSciences's Future ↗

February 28, 2023

Via Benzinga

Earnings Preview For Pacira BioSciences ↗

February 27, 2023

Via Benzinga

Where Pacira BioSciences Stands With Analysts ↗

January 31, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 08, 2023

Friday's session saw 225 companies set new 52-week lows.

Via Benzinga

Why Pacira BioSciences Shares Are Trading Lower Today ↗

May 03, 2023

Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the

Via Benzinga

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

January 23, 2023

On Monday, 12 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.